Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Klein

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Oncotarget|August 23, 2012
Development of gene expression-based risk score in cytogenetically normal acute myeloid leukemia patientsElias Bou Samra, Bernard Klein, Thérèse Commes, et al.
Biomed Research International|June 3, 2014
Identification of a 20-gene expression-based risk score as a predictor of clinical outcome in chronic lymphocytic leukemia patientsElias Bou Samra, Bernard Klein, Thérèse Commes, et al.
Annals of the New York Academy of Sciences|June 12, 2010
Thymosin beta4 in multiple myeloma: friend or foeJo Caers, Eleonore Otjacques, Dirk Hose, et al.
Haematologica|November 27, 2010
γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibodyMounia Sabrina Braza, Bernard Klein, Geneviève Fiol, et al.
BMC Cancer|March 18, 2009
APRIL is overexpressed in cancer: link with tumor progressionJérôme Moreaux, Jean-Luc Veyrune, John De Vos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Interleukin-6 as a therapeutic targetJean-François Rossi, Zhao-Yang Lu, Michel Jourdan, et al.
Oncotarget|October 27, 2015
EZH2 in normal hematopoiesis and hematological malignanciesLaurie Herviou, Giacomo Cavalli, Guillaume Cartron, et al.
Biomarker Research|February 16, 2016
RECQ helicases are deregulated in hematological malignancies in association with a prognostic valueElena Viziteu, Alboukadel Kassambara, Philippe Pasero, et al.
Blood|March 29, 2003
Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiationKarin Tarte, Fenghuang Zhan, John De Vos, et al.
Journal of Translational Medicine|May 24, 2011
SULFs in human neoplasia: implication as progression and prognosis factorsCaroline Bret, Jérôme Moreaux, Jean-François Schved, et al.
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Oncotarget|August 23, 2012
Development of gene expression-based risk score in cytogenetically normal acute myeloid leukemia patientsElias Bou Samra, Bernard Klein, Thérèse Commes, et al.
Biomed Research International|June 3, 2014
Identification of a 20-gene expression-based risk score as a predictor of clinical outcome in chronic lymphocytic leukemia patientsElias Bou Samra, Bernard Klein, Thérèse Commes, et al.
Annals of the New York Academy of Sciences|June 12, 2010
Thymosin beta4 in multiple myeloma: friend or foeJo Caers, Eleonore Otjacques, Dirk Hose, et al.
Haematologica|November 27, 2010
γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibodyMounia Sabrina Braza, Bernard Klein, Geneviève Fiol, et al.
BMC Cancer|March 18, 2009
APRIL is overexpressed in cancer: link with tumor progressionJérôme Moreaux, Jean-Luc Veyrune, John De Vos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Interleukin-6 as a therapeutic targetJean-François Rossi, Zhao-Yang Lu, Michel Jourdan, et al.
Oncotarget|October 27, 2015
EZH2 in normal hematopoiesis and hematological malignanciesLaurie Herviou, Giacomo Cavalli, Guillaume Cartron, et al.
Biomarker Research|February 16, 2016
RECQ helicases are deregulated in hematological malignancies in association with a prognostic valueElena Viziteu, Alboukadel Kassambara, Philippe Pasero, et al.
Blood|March 29, 2003
Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiationKarin Tarte, Fenghuang Zhan, John De Vos, et al.
Journal of Translational Medicine|May 24, 2011
SULFs in human neoplasia: implication as progression and prognosis factorsCaroline Bret, Jérôme Moreaux, Jean-François Schved, et al.
Pageof 13